Hosted on MSN2h
AlzeCure Pharma secures €2.5m grant for Phase IIa trial of Alzheimer’s treatment
The trial will explore the effects of higher doses of ACD856, building on the drug’s established safety profile.
Common osteoporosis treatment drug shows promise against rare type of heart disease
A research team co-led by scientists at the University of Arizona College of Medicine—Tucson found that an osteoporosis drug ...
FDA To Review Teva and Alvotech Drug That Could Compete With Regeneron's Eylea
Teva Pharmaceutical Industries and partner Alvotech said the Food and Drug Administration agreed to review their AVTO6 ...
Innate Pharma Shares Rise After Breakthrough Therapy Designation for Lacutamab
Innate Pharma shares were up 16% to $2.25 after the company said the Food and Drug Administration has granted Breakthrough Therapy Designation to lacutamab for the treatment of adult patients with ...
GlobalData on MSN13h
Hanmi Pharmaceuticals reports data from trial of Tivumecirnon for gastric cancer
South Korea-based Hanmi Pharmaceutical has reported positive outcomes from a Phase I/II clinical trial of Tivumecirnon alongside MSD's Keytruda (pembrolizumab) for advanced or metastatic gastric ...